Companies Cryptocurrencies
Trinity Biotech PLC
Trinity Biotech PLC
Exchange: Nasdaq Global Select
IPO Date: 21/10/1992
CEO: Brendan Farrell
Diagnostics & Research Healthcare 🔗
  • TRIB
  • 2.08
  • 43475536
    market cap
  • -0.01999998
If you bought

shares of Trinity Biotech PLC (TRIB) on
You would have made
Old Price $12 Current Price $12

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow and currently employs 575 full-time employees. The firm’s products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech’s blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.

Address: Bray Co Wicklow Ireland BRAY WICKLOW

Stay updated.